ARCHIVES

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | March 24, 2006

Download PDF Visit The Full Archive

Related Articles

DCE Board Gives Concept Approval To Eight Contract Recompetitions

July 20, 1984

In Brief: Muggia Leaving NCI For NYU In September; Seminar Planned On radiation Exposures

April 20, 1979

The Cancer Letter Provides Full Text Of Publications To University Of Kentucky.

October 19, 2001

Van Potter Wins Bristol-Myers Award

April 24, 1981

NIH Panel Calls for Further Research On End-of-Life Issues.

January 21, 2005

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014